tiprankstipranks
Trending News
More News >
Insmed (INSM)
NASDAQ:INSM

Compare Insmed (INSM) vs. Competitors

Compare
1,056 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Insmed
$157.82
$33.25B
102.33%
18 Buy
1 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$56.68
$10.89B
21.35
-10.20%
8 Buy
5 Hold
0 Sell
Moderate Buy
Incyte
$101.18
$19.86B
16.96
37.11%
7 Buy
8 Hold
1 Sell
Moderate Buy
Genmab
$32.93
$20.13B
14.05
68.01%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$116.16
$27.93B
-44.41
-3.62%
12 Buy
2 Hold
0 Sell
Strong Buy
Royalty Pharma
$40.41
$23.33B
23.11
27.89%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INSM
Insmed
157.82
81.53
106.87%
BMRN
BioMarin Pharmaceutical
56.99
-6.89
-10.79%
INCY
Incyte
101.08
27.31
37.02%
GMAB
Genmab
33.35
13.54
68.35%
BNTX
BioNTech SE
116.77
-4.11
-3.40%
RPRX
Royalty Pharma
40.86
10.05
32.62%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts